OKTREOTID TEVA

Powder and solvent for prolonged-release suspension for injection, 20mg
RxActive license

Active substance (INN)

octreotide

Pharmaceutical form

Pharmaceutical formPowder and solvent for prolonged-release suspension for injection
Strength20mg
PackagingUkupno 1 bočica staklena sa praškom za suspenziju za injekciju i 1 napunjeni injekcioni špric sa rastvaračem u kartonskoj kutiji
ManufacturerMerckle GmbH, Germany
Therapeutic groupSystemic hormonal preparations (H01CB02)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateOctober 11, 2022

Analogs in Montenegro

6

Other medicines with the same active substance

OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 30mgMerckle GmbH
OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 10mgMerckle GmbH
SANDOSTATINRx
Solution for injection/infusion, 0.1mg/mlNovartis Pharma Stein AG
SANDOSTATIN LARRx
Powder and solvent for suspension for injection, 10mgNovartis Farmaceutica S.A.
SANDOSTATIN LARRx
Powder and solvent for suspension for injection, 20 mgNovartis Farmaceutica S.A.
SANDOSTATIN LARRx
Powder and solvent for suspension for injection, 30mgNovartis Farmaceutica S.A.
Source: CInMED register